We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+6.21%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$907M
AUM Growth
+$198M
Cap. Flow
+$174M
Cap. Flow %
19.24%
Top 10 Hldgs %
37.32%
Holding
434
New
22
Increased
336
Reduced
40
Closed
7

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$24.7M
2
MSFT icon
Microsoft
MSFT
+$10.9M
3
AMGN icon
Amgen
AMGN
+$7.39M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7M
5
NVDA icon
NVIDIA
NVDA
+$6.68M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$6.5M
2
NOW icon
ServiceNow
NOW
+$4.69M
3
CRM icon
Salesforce
CRM
+$4.67M
4
CRWD icon
CrowdStrike
CRWD
+$4.38M
5
QCOM icon
Qualcomm
QCOM
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 37.6%
2 Healthcare 28.11%
3 Consumer Discretionary 12.57%
4 Communication Services 9.53%
5 Consumer Staples 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRY icon
276
ARS Pharmaceuticals
SPRY
$601M
$270K 0.03%
18,645
+7,262
+64% +$86.4K
DAWN
277
DELISTED
Day One Biopharmaceuticals
DAWN
$267K 0.03%
19,203
+8,935
+87% +$127K
OCUL icon
278
Ocular Therapeutix
OCUL
$2.25B
$261K 0.03%
29,989
+11,793
+65% +$97.2K
WBD icon
279
Warner Bros
WBD
$69.3B
$257K 0.03%
31,100
+16,368
+111% +$128K
MDB icon
280
MongoDB
MDB
$35.2B
$253K 0.03%
937
+496
+112% +$129K
AVDL
281
DELISTED
Avadel Pharmaceuticals
AVDL
$243K 0.03%
18,516
+7,224
+64% +$110K
ANIP icon
282
ANI Pharmaceuticals
ANIP
$1.73B
$241K 0.03%
4,045
+1,582
+64% +$96.5K
TARS icon
283
Tarsus Pharmaceuticals
TARS
$3.07B
$241K 0.03%
7,317
+2,879
+65% +$80.9K
COLL icon
284
Collegium Pharmaceutical
COLL
$834M
$239K 0.03%
6,196
+2,352
+61% +$83.9K
XNCR icon
285
Xencor
XNCR
$1.72B
$239K 0.03%
11,893
+4,650
+64% +$87.3K
PHAT icon
286
Phathom Pharmaceuticals
PHAT
$742M
$237K 0.03%
13,134
+6,257
+91% +$87.5K
INVA icon
287
Innoviva
INVA
$1.5B
$232K 0.03%
12,033
+4,698
+64% +$86.6K
ELVN icon
288
Enliven Therapeutics
ELVN
$4.24B
$232K 0.03%
9,085
+3,559
+64% +$82.4K
IMCR icon
289
Immunocore
IMCR
$1.77B
$231K 0.03%
7,433
+3,053
+70% +$111K
ZLAB icon
290
Zai Lab
ZLAB
$2.86B
$231K 0.03%
9,559
+3,514
+58% +$66.4K
COGT icon
291
Cogent Biosciences
COGT
$6.76B
$227K 0.03%
21,051
+9,819
+87% +$95.6K
ARM icon
292
Arm
ARM
$290B
$227K 0.03%
1,587
+876
+123% +$124K
MRVI icon
293
Maravai LifeSciences
MRVI
$861M
$226K 0.02%
27,225
+11,621
+74% +$100K
CNTA
294
DELISTED
Centessa Pharmaceuticals
CNTA
$217K 0.02%
13,593
+6,785
+100% +$83.1K
ARQT icon
295
Arcutis Biotherapeutics
ARQT
$3.3B
$209K 0.02%
22,482
+8,881
+65% +$87.6K
GRFS
296
Grifois
GRFS
$5.4B
$208K 0.02%
23,464
+9,130
+64% +$74.3K
TVTX icon
297
Travere Therapeutics
TVTX
$5.86B
$206K 0.02%
14,712
+5,767
+64% +$60.1K
VIK icon
298
Viking Holdings
VIK
$46.5B
$204K 0.02%
+5,844
New +$200K
AUPH icon
299
Aurinia Pharmaceuticals
AUPH
$2.06B
$202K 0.02%
27,502
+10,700
+64% +$66.3K
VIR icon
300
Vir Biotechnology
VIR
$1.52B
$197K 0.02%
26,280
+10,294
+64% +$89.4K
10 11
12
13 14

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2024 Portfolio in Review

As of Q3 2024, China Universal Asset Management Company held 434 positions worth $907M, up 28% from $709M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $174M of net new capital in Q3 2024, opening 22 new positions and adding to 336 existing holdings. Its largest new stake was SAP: 16,500 shares worth $3.78M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 44% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Micron Technology, an estimated $6.5M trimmed.

  • China Universal Asset Management Company's largest Q3 2024 buy was SAP: 16,500 shares worth $3.78M.
  • China Universal Asset Management Company added most to Apple in Q3 2024, an estimated $24.7M increase.
  • China Universal Asset Management Company's biggest Q3 2024 reduction was Micron Technology, cutting an estimated $6.5M.
  • China Universal Asset Management Company fully exited Tencent Music in Q3 2024, selling an estimated $2.89M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $907M portfolio in Q3 2024.
  • China Universal Asset Management Company opened 22 new positions and closed 7 in Q3 2024.
  • China Universal Asset Management Company's portfolio value rose 28% quarter-over-quarter to $907M.

Based on China Universal Asset Management Company's 13F filing for Q3 2024, filed 25 Oct 2024.